دوره 3، شماره 3 و 4 - ( 8-1395 )                   جلد 3 شماره 3 و 4 صفحات 63-60 | برگشت به فهرست نسخه ها


XML English Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Afrough P, Behrouzi A, Davari M, Malekan M, Fateh A, Vaziri F et al . Cloning and expression of porA gene as the first step of a vaccine candidate study against Neisseria meningitidis serogroup A infection. vacres 2016; 3 (3 and 4) :60-63
URL: http://vacres.pasteur.ac.ir/article-1-93-fa.html
Cloning and expression of porA gene as the first step of a vaccine candidate study against Neisseria meningitidis serogroup A infection. Vaccine Research. 1395; 3 (3 و 4) :60-63

URL: http://vacres.pasteur.ac.ir/article-1-93-fa.html


چکیده:   (6235 مشاهده)

Introduction: Neisseria meningitidis is a major causative agent of bacterial septicemia and meningitis in human. PorA is a major component of the outer membrane of N. meningitidis and functions as a cationic Porin. This study aimed to clone and determine the expression of PorA as the first step for producing a proper antigen in a vaccine study against N. meningitidis. Methods: An approximately 1200-bp fragment of porA gene was amplified by PCR using                  N. meningitidis serogroup A genomic DNA and then cloned into prokaryotic expression vector pET-28a. The resulting construct (pET28a-porA plasmid) was transformed into competent E.coli BL21 cells for expression of recombinant protein. The proper overexpression of the recombinant protein was verified by SDS-PAGE and Western Blotting. Results: Cloning of porA was confirmed by colony-PCR and enzymatic digestion. The nucleotide sequence homology of the cloned porA gene was 97% , compared to the reference gene (NCBI GenBank accession number AL157959.1). The prokaryotic expression system (pET28a-porA- BL21) could  produce our 45-kDa target recombinant protein, efficiently. Conclusion: The prokaryotic expression system and conditions used in this study provides an applicable method for producing recombinant PorA and possibly many other bacterial outer membrane proteins for future vaccine studies.

متن کامل [PDF 397 kb]   (1678 دریافت)    
نوع مطالعه: Original article |
دریافت: 1396/1/26

ارسال نظر درباره این مقاله : نام کاربری یا پست الکترونیک شما:
CAPTCHA

بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.

کلیه حقوق این وب سایت متعلق به Vaccine Research می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2024 All Rights Reserved | Vaccine Research

Designed & Developed by : Yektaweb

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.